Bausch & Lomb Corp (BLCO) shareholders
Close on Nov 17, 2026Market cap $7.45BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BLCO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Icahn Carl C | 3,500,000 | 0.98% | $57.96M | – | 0.70% |
| Oaktree Capital Management LP | 3,441,042 | 0.96% | $56.98M | +58,303 | 0.79% |
| Deutsche Bank AG\ | 3,423,046 | 0.96% | $56.69M | −105,395 | 0.02% |
| D. E. Shaw & Co., Inc. | 3,323,021 | 0.93% | $55.03M | +171,854 | 0.03% |
| Davidson Kempner Capital Management LP | 3,158,972 | 0.88% | $52.31M | +959,800 | 0.62% |
| Goldentree Asset Management LP | 2,660,508 | 0.74% | $43.96M | – | 2.56% |
| Price T Rowe Associates Inc /Md/ | 2,161,232 | 0.60% | $35.79M | +936,629 | 0.00% |
| Caspian Capital LP | 1,999,043 | 0.56% | $33.10M | – | 18.80% |
| Glenview Capital Management, LLC | 1,918,148 | 0.54% | $31.76M | +7,652 | 0.58% |
| Arrowstreet Capital, Limited Partnership | 1,364,980 | 0.38% | $22.60M | +382,918 | 0.01% |
| Citadel Advisors LLC | 987,730 | 0.28% | $16.36M | +282,509 | 0.00% |
| Clark Estates Inc/Ny | 881,000 | 0.25% | $14.59M | +56,000 | 3.36% |
| Morgan Stanley | 703,348 | 0.20% | $11.65M | −142,566 | 0.00% |
| Clearline Capital LP | 701,967 | 0.20% | $11.62M | – | 0.69% |
| Whitebox Advisors LLC | 686,976 | 0.19% | $11.38M | −414,878 | 0.15% |
| GordonMD Global Investments LP | 573,472 | 0.16% | $9.50M | – | 4.60% |
| Tudor Investment Corp Et Al | 532,030 | 0.15% | $8.81M | +155,584 | 0.01% |
| UBS Group AG | 465,197 | 0.13% | $7.70M | +12,018 | 0.00% |
| Goldman Sachs Group Inc | 420,194 | 0.12% | $6.96M | +127,308 | 0.00% |
| Sona Asset Management (US) LLC | 404,279 | 0.11% | $6.69M | New | 0.14% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 98 | 38M | 10.7% | 19 / 31 | 30 / 15 | 5M | 5M |
| Q1 2026 | 96 | 38M | 10.6% | 18 / 34 | 26 / 20 | 3M | 5M |
| Q4 2025 | 98 | 40M | 11.1% | 21 / 29 | 32 / 14 | 5M | 4M |
| Q3 2025 | 92 | 39M | 10.8% | 16 / 28 | 30 / 17 | 9M | 9M |
| Q2 2025 | 93 | 38M | 10.7% | 20 / 28 | 25 / 32 | 9M | 7M |
| Q1 2025 | 107 | 37M | 10.3% | 25 / 33 | 33 / 31 | 11M | 8M |
| Q4 2024 | 113 | 34M | 9.6% | 31 / 32 | 32 / 25 | 5M | 8M |
| Q3 2024 | 110 | 38M | 10.6% | 38 / 30 | 25 / 16 | 10M | 13M |
| Q2 2024 | 89 | 41M | 11.4% | 22 / 33 | 19 / 19 | 8M | 5M |
| Q1 2024 | 87 | 38M | 10.6% | 20 / 29 | 23 / 23 | 3M | 4M |
| Q4 2023 | 90 | 39M | 10.9% | 21 / 36 | 16 / 17 | 5M | 9M |
| Q3 2023 | 87 | 43M | 12.0% | 17 / 23 | 24 / 7 | 7M | 8M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
21 funds held BLCO in Q2 2026, 11% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BLCO | Value | % of fund | As of |
|---|---|---|---|---|---|
| T. Rowe Price High Yield Fund, Inc. | 791,542 | 0.22% | $12.39M | 0.20% | May 31, 2026 |
| T. Rowe Price Institutional High Yield Fund | 210,028 | 0.06% | $3.29M | 0.20% | May 31, 2026 |
| T. Rowe Price Dynamic Credit Fund | 204,491 | 0.06% | $3.39M | 0.23% | Jun 30, 2026 |
| Ballast Small/Mid Cap ETF | 147,837 | 0.04% | $2.45M | 1.37% | Jun 30, 2026 |
| T. Rowe Price Global High Income Bond Fund | 61,989 | 0.02% | $1.03M | 0.17% | Jun 30, 2026 |
| T. Rowe Price Credit Opportunities Fund, Inc. | 50,600 | 0.01% | $791.89K | 0.20% | May 31, 2026 |
| The Gabelli Asset Fund | 45,000 | 0.01% | $745.20K | 0.04% | Jun 30, 2026 |
| Strategic Advisers Income Opportunities Fund | 43,655 | 0.01% | $683.20K | 0.04% | May 31, 2026 |
| International Core Equity 2 Portfolio | 15,594 | 0.00% | $263.69K | 0.00% | Jul 31, 2026 |
| 1290 GAMCO Small/Mid Cap Value Fund | 15,000 | 0.00% | $253.65K | 0.11% | Jul 31, 2026 |
| Dimensional World ex. U.S. Core Equity 2 ETF | 13,782 | 0.00% | $233.05K | 0.00% | Jul 31, 2026 |
| World ex U.S. Core Equity Portfolio | 11,157 | 0.00% | $188.66K | 0.00% | Jul 31, 2026 |
| Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF | 9,389 | 0.00% | $112.88K | 0.04% | Jul 31, 2026 |
| International Sustainability Core 1 Portfolio | 7,203 | 0.00% | $121.80K | 0.00% | Jul 31, 2026 |
| Dimensional International Core Equity 2 ETF | 2,558 | 0.00% | $43.26K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Brent L. Saunders | Chairman of the Board and CEO, Director | 974,158 | 0.27% | Aug 7, 2026 |
| Frederick Munsch | SVP, Controller and CAO | 45,831 | 0.01% | Nov 2, 2026 |
| Andrew J. Stewart | President, GPIC | 103,211 | 0.03% | Aug 7, 2026 |
| Luc Bonnefoy | President, Surgical | 103,801 | 0.03% | Aug 7, 2026 |
| A. Robert D. Bailey | EVP & Chief Legal Officer | 264,241 | 0.07% | Aug 7, 2026 |
| Sam Eldessouky | EVP and CFO | 393,527 | 0.11% | Aug 7, 2026 |
| Yehia Hashad | EVP of R&D and CMO | 187,350 | 0.05% | Aug 7, 2026 |
| Eduardo Alfonso | Director | 32,197 | 0.01% | Nov 2, 2026 |
| John Paulson | Director | 90,948 | 0.03% | Nov 2, 2026 |
| Russel C. Robertson | Director | 95,516 | 0.03% | Nov 2, 2026 |
| Thomas Appio | Director | 27,583 | 0.01% | Aug 14, 2026 |
| Laurence E. Paul | Director | 11,776 | 0.00% | Aug 14, 2026 |
| Robert J. Chersi | Director | 11,776 | 0.00% | Aug 14, 2026 |
| Barbara Trebbi | Director | 11,776 | 0.00% | Aug 14, 2026 |
| Eschenbach Andrew C. Von | Director | 63,733 | 0.02% | Aug 10, 2026 |
| Thomas W. Ross Sr. | Director | 85,233 | 0.02% | May 28, 2026 |
| Sarah B. Kavanagh | Director | 69,541 | 0.02% | May 28, 2026 |
| Karen Ling | Director | 61,518 | 0.02% | May 28, 2026 |
| Steven H. Collis | Director | 42,003 | 0.01% | May 28, 2026 |
| Nathalie D. Bernier | Director | 85,505 | 0.02% | May 28, 2026 |
| Brett Icahn | Director | 61,147 | 0.02% | May 28, 2025 |
| Gaoxiang Hu | Director | 61,147 | 0.02% | May 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Frederick Munsch SVP, Controller and CAO | Oct 29, 2026 | Sale | −112,015 | $20.48 | $2.29M | 45,831 |
| Frederick Munsch SVP, Controller and CAO | Oct 29, 2026 | Option exercise | +87,912 | $18.00 | $1.58M | 157,846 |
| Frederick Munsch SVP, Controller and CAO | Oct 29, 2026 | Option exercise | +24,103 | $17.96 | $432.89K | 69,934 |
| Russel C. Robertson Director | Oct 29, 2026 | Award | +1,256 | $20.40 | $25.62K | 95,516 |
| John Paulson Director | Oct 29, 2026 | Award | +1,125 | $20.40 | $22.95K | 90,948 |
| Eduardo Alfonso Director | Oct 29, 2026 | Award | +1,125 | $20.40 | $22.95K | 32,197 |
| Robert J. Chersi Director | Aug 12, 2026 | Award | +11,776 | – | – | 11,776 |
| Barbara Trebbi Director | Aug 12, 2026 | Award | +11,776 | – | – | 11,776 |
| Laurence E. Paul Director | Aug 12, 2026 | Award | +11,776 | – | – | 11,776 |
| Frederick Munsch SVP, Controller and CAO | Aug 10, 2026 | Sale | −52,900 | $16.78 | $887.66K | 45,831 |
| Eschenbach Andrew C. Von Director | Aug 7, 2026 | Sale | −6,059 | $16.58 | $100.46K | 63,733 |
| Eschenbach Andrew C. Von Director | Aug 6, 2026 | Sale | −12,500 | $16.50 | $206.25K | 69,792 |
| Yehia Hashad EVP of R&D and CMO | Aug 5, 2026 | Award | +20,973 | – | – | 187,350 |
| Andrew J. Stewart President, GPIC | Aug 5, 2026 | Award | +16,778 | – | – | 103,211 |
| Sam Eldessouky EVP and CFO | Aug 5, 2026 | Award | +50,335 | – | – | 393,527 |
| A. Robert D. Bailey EVP & Chief Legal Officer | Aug 5, 2026 | Award | +33,557 | – | – | 264,241 |
| Luc Bonnefoy President, Surgical | Aug 5, 2026 | Award | +16,778 | – | – | 103,801 |
| Frederick Munsch SVP, Controller and CAO | Aug 5, 2026 | Award | +9,091 | – | – | 98,731 |
| Brent L. Saunders Chairman of the Board and CEO, Director | Aug 5, 2026 | Tax withholding | −4,231 | $16.76 | $70.91K | 974,158 |
| Brent L. Saunders Chairman of the Board and CEO, Director | Aug 5, 2026 | Award | +281,879 | – | – | 1,256,037 |
| Luc Bonnefoy President, Surgical | Jun 12, 2026 | Tax withholding | −1,008 | $15.08 | $15.20K | 87,023 |
| Steven H. Collis Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 42,003 |
| John Paulson Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 89,823 |
| Thomas W. Ross Sr. Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 85,233 |
| Nathalie D. Bernier Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 85,505 |
| Karen Ling Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 61,518 |
| Eschenbach Andrew C. Von Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 86,656 |
| Russel C. Robertson Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 94,260 |
| Eduardo Alfonso Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 31,072 |
| Sarah B. Kavanagh Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 69,541 |
| Brent L. Saunders Chairman of the Board and CEO, Director | May 22, 2026 | Tax withholding | −2,886 | $15.92 | $45.95K | 978,389 |
| Yehia Hashad EVP of R&D and CMO | May 5, 2026 | Tax withholding | −13,664 | $16.00 | $218.62K | 166,377 |
| Frederick Munsch SVP, Controller and CAO | May 5, 2026 | Tax withholding | −8,673 | $16.00 | $138.77K | 89,640 |
| Luc Bonnefoy President, Surgical | May 5, 2026 | Tax withholding | −11,970 | $16.00 | $191.52K | 88,031 |
| Sam Eldessouky EVP and CFO | May 5, 2026 | Tax withholding | −63,938 | $16.00 | $1.02M | 343,192 |
| Eduardo Alfonso Director | Apr 30, 2026 | Award | +1,375 | $15.90 | $21.86K | 15,230 |
| John Paulson Director | Apr 30, 2026 | Award | +1,375 | $15.90 | $21.86K | 73,981 |
| Russel C. Robertson Director | Apr 30, 2026 | Award | +1,611 | $15.90 | $25.61K | 78,418 |
| Steven H. Collis Director | Apr 30, 2026 | Award | +1,415 | $15.90 | $22.50K | 26,161 |
| A. Robert D. Bailey EVP & Chief Legal Officer | Apr 24, 2026 | Tax withholding | −15,806 | $15.82 | $250.05K | 230,684 |
| Andrew J. Stewart President, GPIC | Apr 24, 2026 | Tax withholding | −4,216 | $15.82 | $66.70K | 86,433 |
| Sam Eldessouky EVP and CFO | Mar 6, 2026 | Award | +4,000 | – | – | 407,130 |
| Sam Eldessouky EVP and CFO | Mar 6, 2026 | Buy | +4,000 | $17.13 | $68.52K | 403,130 |
| Brent L. Saunders CEO and Chairman of the Board, Director | Mar 6, 2026 | Buy | +14,700 | $17.14 | $251.96K | 966,575 |
| Brent L. Saunders CEO and Chairman of the Board, Director | Mar 6, 2026 | Award | +14,700 | – | – | 981,275 |
| A. Robert D. Bailey EVP & Chief Legal Officer | Mar 6, 2026 | Buy | +14,600 | $17.15 | $250.39K | 231,890 |
| A. Robert D. Bailey EVP & Chief Legal Officer | Mar 6, 2026 | Award | +14,600 | – | – | 246,490 |
| Thomas W. Ross Sr. Director | Mar 3, 2026 | Award | +4,500 | – | – | 69,391 |
| Thomas W. Ross Sr. Director | Mar 3, 2026 | Buy | +4,500 | $17.68 | $79.56K | 64,891 |
| Eduardo Alfonso Director | Mar 2, 2026 | Award | +4,300 | – | – | 13,855 |
| Eduardo Alfonso Director | Mar 2, 2026 | Buy | +4,300 | $17.90 | $76.97K | 9,555 |
| Eschenbach Andrew C. Von Director | Feb 27, 2026 | Buy | +4,364 | $18.31 | $79.90K | 66,450 |
| Eschenbach Andrew C. Von Director | Feb 27, 2026 | Award | +4,364 | – | – | 70,814 |
| Andrew J. Stewart President, GPIC | Feb 27, 2026 | Tax withholding | −2,007 | $18.30 | $36.73K | 90,649 |
| A. Robert D. Bailey EVP & Chief Legal Officer | Feb 27, 2026 | Tax withholding | −2,461 | $18.30 | $45.04K | 217,290 |
| Yehia Hashad EVP of R&D and CMO | Feb 27, 2026 | Tax withholding | −11,621 | $18.30 | $212.66K | 180,041 |
| Yehia Hashad EVP of R&D and CMO | Feb 27, 2026 | Tax withholding | −5,075 | $18.30 | $92.87K | 191,662 |
| Sam Eldessouky EVP and CFO | Feb 27, 2026 | Tax withholding | −15,507 | $18.30 | $283.78K | 450,600 |
| Sam Eldessouky EVP and CFO | Feb 27, 2026 | Tax withholding | −51,470 | $18.30 | $941.90K | 399,130 |
| Luc Bonnefoy President, Surgical | Feb 27, 2026 | Tax withholding | −4,311 | $18.30 | $78.89K | 109,222 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Bausch & Lomb's stock actually held short. Settlement fails (shares not delivered on time) peaked at 19,235 shares on Sep 1, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Nathalie D. Bernier Former Director | Nov 3, 2026 | 40,022 | $795.73K | Nov 3, 2026 | Restricted Stock Vesting |
| Frederick Munsch Officer | Oct 29, 2026 | 112,015 | $2.29M | Oct 29, 2026 | Stock Option Exercise |
| Karen Ling Former Director | Sep 28, 2026 | 4,500 | $75.74K | Sep 28, 2026 | Restricted Stock Vesting |
| Frederick Munsch Officer | Aug 11, 2026 | 52,900 | $887.89K | Aug 10, 2026 | Restricted Stock Vesting |
| Frederick Munsch Former Officer | Aug 10, 2026 | 52,900 | $887.89K | Aug 10, 2026 | Restricted Stock Vesting |
| Eschenbach Andrew C. Von Former Director | Aug 7, 2026 | 6,059 | $100.43K | Aug 7, 2026 | Open market purchase |
| Eschenbach Andrew C. Von Former Director | Aug 6, 2026 | 12,500 | $206.19K | Aug 6, 2026 | Restricted Stock Vesting |
See a number that looks wrong?